Arcadia Biosciences, Inc.
RKDA
$3.11
$0.1153.85%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 1.60M | 1.39M | 1.51M | 1.00M | 1.57M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.60M | 1.39M | 1.51M | 1.00M | 1.57M |
| Cost of Revenue | 1.40M | 1.37M | 1.18M | -419.00K | 1.38M |
| Gross Profit | 193.00K | 20.00K | 325.00K | 1.42M | 187.00K |
| SG&A Expenses | 3.45M | 3.82M | 4.39M | 4.21M | 4.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.85M | 5.19M | 5.58M | 3.80M | 5.56M |
| Operating Income | -3.25M | -3.80M | -4.07M | -2.80M | -3.99M |
| Income Before Tax | -2.48M | 819.00K | -9.38M | -4.32M | -2.29M |
| Income Tax Expenses | -- | 1.00K | -- | 13.00K | 1.00K |
| Earnings from Continuing Operations | -2.48M | 818.00K | -9.38M | -4.33M | -2.29M |
| Earnings from Discontinued Operations | -83.00K | -- | -- | -- | -589.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 5.00K | -- | 84.00K | 10.00K |
| Net Income | -2.57M | 823.00K | -9.38M | -4.24M | -2.87M |
| EBIT | -3.25M | -3.80M | -4.07M | -2.80M | -3.99M |
| EBITDA | -3.16M | -3.73M | -4.00M | -2.71M | -3.90M |
| EPS Basic | -1.89 | 0.61 | -10.86 | -6.30 | -4.67 |
| Normalized Basic EPS | -1.15 | 0.38 | -6.80 | -1.06 | -2.31 |
| EPS Diluted | -1.89 | 0.61 | -10.86 | -6.45 | -4.67 |
| Normalized Diluted EPS | -1.15 | 0.38 | -6.80 | -1.06 | -2.31 |
| Average Basic Shares Outstanding | 1.36M | 1.36M | 864.40K | 673.70K | 613.80K |
| Average Diluted Shares Outstanding | 1.36M | 1.36M | 864.40K | 673.70K | 613.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
